Division of Nephrology and Hypertension, Department of Medicine, Northwestern University, Chicago, IL, USA.
Am J Transplant. 2012 Sep;12(9):2335-47. doi: 10.1111/j.1600-6143.2012.04120.x. Epub 2012 Jun 8.
CD4(+) regulatory T cells play a critical role in tolerance induction in transplantation. CD8(+) suppressor T cells have also been shown to control alloimmune responses in preclinical and clinical models. However, the exact nature of the CD8(+) suppressor T cells, their induction and mechanism of function in allogeneic transplantation remain elusive. In this study, we show that functionally suppressive, alloantigen-specific CD8(+) Foxp3(+) T cells can be induced and significantly expanded by stimulating naïve CD8(+) T cells with donor dendritic cells in the presence of IL-2, TGF-β1 and retinoic acid. These CD8(+) Foxp3(+) T cells express enhanced levels of CTLA-4, CCR4 and CD103, inhibit the up-regulation of costimulatory molecules on dendritic cells, and suppress CD4 and CD8 T cell proliferation and cytokine production in a donor-specific and contact-dependent manner. Importantly, upon adoptive transfer, the induced CD8(+) Foxp3(+) T cells protect full MHC-mismatched skin allografts. In vivo, the CD8(+) Foxp3(+) T cells preferentially traffic to the graft draining lymph node where they induce conventional CD4(+) Foxp3(+) T cells and concurrently suppress effector T cell expansion. We conclude that donor-specific CD8(+) Foxp3(+) suppressor T cells can be induced and exploited as an effective form of cell therapy for graft protection in transplantation.
CD4(+) 调节性 T 细胞在移植中的耐受诱导中发挥关键作用。CD8(+) 抑制性 T 细胞也已被证明可以控制临床前和临床模型中的同种免疫反应。然而,CD8(+) 抑制性 T 细胞的确切性质、其在同种异体移植中的诱导和作用机制仍不清楚。在这项研究中,我们表明,通过在 IL-2、TGF-β1 和维甲酸存在的情况下用供体树突状细胞刺激幼稚 CD8(+) T 细胞,可以诱导和显著扩增具有功能抑制性、同种抗原特异性的 CD8(+) Foxp3(+) T 细胞。这些 CD8(+) Foxp3(+) T 细胞表达增强水平的 CTLA-4、CCR4 和 CD103,抑制树突状细胞上共刺激分子的上调,并以供体特异性和接触依赖性方式抑制 CD4 和 CD8 T 细胞的增殖和细胞因子产生。重要的是,在过继转移后,诱导的 CD8(+) Foxp3(+) T 细胞保护完全 MHC 错配的皮肤同种异体移植物。在体内,CD8(+) Foxp3(+) T 细胞优先迁移到移植物引流淋巴结,在那里它们诱导常规 CD4(+) Foxp3(+) T 细胞,并同时抑制效应 T 细胞的扩增。我们得出结论,供体特异性 CD8(+) Foxp3(+) 抑制性 T 细胞可以被诱导并作为移植中移植物保护的有效细胞治疗形式加以利用。